425: Strive Files Pro Forma Financials for Semler Scientific Merger

Strive, Inc. filed pro forma financial information and historical statements for Semler Scientific in connection with their pending all-stock merger agreement.

Summary

• Strive, Inc. is acquiring Semler Scientific, Inc. in an all-stock transaction, with the merger agreement signed on September 22, 2025, and unanimously approved by both companies' boards on September 21, 2025.
• Each outstanding share of Semler Scientific common stock will be converted into the right to receive 21.05 shares of Strive Class A common stock.
• Strive is deemed the accounting acquirer, meaning its historical financial statements will form the basis of the combined entity, and Semler Scientific's assets and liabilities will be recognized at fair value.
• The filing includes unaudited pro forma combined consolidated financial information, giving effect to the merger as if it occurred on January 1, 2024, for the statement of operations, and September 30, 2025, for the balance sheet.
• The preliminary estimated purchase price consideration for Semler Scientific is approximately $471.7 million.
• An accrual of $10.1 million for non-recurring acquisition-related expenses is reflected in the pro forma financials.

Sentiment

Score: 6

Explanation: The filing announces a strategic all-stock merger unanimously approved by both boards, which is generally a positive indicator of strategic alignment. However, the pro forma combined financials for the nine months ended September 30, 2025, show a substantial net loss, which introduces a degree of caution regarding the immediate financial impact. The long list of risks also warrants careful consideration.

Positives

• The merger was unanimously approved by the boards of directors of both Strive and Semler Scientific, indicating strong internal support for the strategic combination.
• The transaction is structured as an all-stock acquisition, which typically avoids immediate cash outflow for the acquiring company.
• Strive's existing stockholders are expected to retain the greatest voting interest and control the strategic direction of the combined entity, ensuring continuity of leadership.

Negatives

• The pro forma combined net loss for the nine months ended September 30, 2025, is substantial at $(200,145) thousand, indicating potential near-term financial challenges for the combined entity.
• Pro forma combined operating expenses for the nine months ended September 30, 2025, are significantly higher than revenues, at $98,647 thousand versus $29,020 thousand.
• An accrual of $10.1 million for non-recurring acquisition-related expenses is highlighted, indicating significant transaction costs associated with the merger.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, and the implementation of Bitcoin treasury strategies, could impact the realization of anticipated benefits.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could affect the combined company's future results.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing includes standard forward-looking statements regarding the proposed transaction's strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, it also cautions that actual results could differ materially due to various risks and uncertainties, including those related to Bitcoin treasury strategies and integration challenges.

Management Comments

• Strive's senior management is expected to control the strategic direction of Strive following consummation of the Semler Merger.
• Strive's existing directors will control the majority of the post business combination board.

Industry Context

Strive, a bitcoin treasury asset management firm, is expanding its operations through the acquisition of Semler Scientific. This move suggests a strategic effort to consolidate or diversify within the digital asset and broader financial services sector, potentially leveraging Semler Scientific's existing infrastructure or market position to enhance Strive's investment advisory and management services, particularly in the context of bitcoin and bitcoin-related products. The emphasis on Bitcoin treasury strategies highlights a growing trend among companies to integrate digital assets into their corporate finance.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company related to the merger is a potential risk.

Stakeholder Impact

• Shareholders (Strive): Potential dilution due to issuance of new Class A common stock; potential for long-term value creation if strategic benefits are realized; exposure to Semler Scientific's business and risks.
• Shareholders (Semler Scientific): Will receive Strive Class A common stock, converting their ownership into shares of the combined entity; subject to Strive's performance and risks.
• Customers: Potential for adverse reactions or changes to business relationships due to the merger.
• Employees: Potential for changes to employee relationships or integration challenges.
• Management: Diversion of attention from ongoing business operations during the integration process.

Next Steps

• Completion of the pending merger transaction between Strive and Semler Scientific.
• Semler Scientific stockholders will need to approve the proposed transaction.
• Strive will issue Class A common stock to Semler Scientific stockholders.
• Final acquisition accounting, including valuation analysis and other studies, will be completed after the closing of the transaction.

Key Dates

Recommendation

The all-stock merger with Semler Scientific represents a significant strategic move for Strive, aiming to leverage synergies and expand its market presence, particularly in the digital asset space. The unanimous board approval suggests strong internal conviction. However, the pro forma financials reveal a substantial combined net loss for the nine months ended September 30, 2025, and the transaction involves considerable integration risks and potential dilution for existing Strive shareholders. While the long-term strategic benefits could be compelling, the immediate financial outlook and execution risks warrant a cautious 'hold' stance until more clarity emerges on integration success and financial performance post-merger.

Keywords

Merger, Acquisition, Strive Inc., Semler Scientific, All-stock acquisition, Pro forma financials, SEC filing, Form 425, Bitcoin treasury, Digital assets, Corporate governance, Financial reporting